Incesu, who assumed her role in 2020, first joined AstraZeneca in 2000. In 2023, AstraZeneca MEA recorded a revenue growth of 25.7% and received 97 medicine approvals, 35 of which were accelerated. Incesu is the international leader sponsor on AstraZeneca’s Global Inclusion & Diversity Council. She leads five MEA units and oversees a team of over 2,300 people.